Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715026 · ClinicalTrials.gov registry record · Phase 4
Trilogy AB Acetabular Hip System Post Approval Study
A Phase 4 study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00715026: Clinical Trial Phase 4 study, sponsored by Zimmer Biomet.
NCT00715026 is a Phase 4 study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 31 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00715026, a Phase 4 study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.
Primary Outcome
The Harris Hip Score was developed to assess hip disabilities and methods of treatment and has been in use for decades. It evaluates patients on the basis of pain, function, absence of deformity and range of motion. The Harris Hip Score could range from 0 to 100. Scores less then 70 are poor, scores 70 to 79 are fair, scores 80 to 89 are good, and scores 90 to 100 are excellent.
Interventions
- DEVICE Trilogy AB Acetabular Hip Implant System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Why NCT00715026 stopped before completion
NCT00715026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Trilogy AB Acetabular Hip Implant System is the first listed.
NCT00715026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00715026 about?
NCT00715026 is a clinical study titled "Trilogy AB Acetabular Hip System Post Approval Study". This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip Sy...
What is the current status of trial NCT00715026?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2009-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00715026?
The interventions under investigation include: Trilogy AB Acetabular Hip Implant System (DEVICE).
Who is sponsoring clinical trial NCT00715026?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00715026's enrollment target sits among peer trials
31 1544th of 2000 higher than 449 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia